Kim Bure

Latest from Kim Bure

Quality By Design for Advanced Therapies: An Informed Route to Enhanced Late-Stage Clinical Success and Empowered Process Flexibility
Cell Therapies
Quality By Design for Advanced Therapies: An Informed Route to Enhanced Late-Stage Clinical Success and Empowered Process FlexibilityQuality By Design for Advanced Therapies: An Informed Route to Enhanced Late-Stage Clinical Success and Empowered Process Flexibility
byKim Bure, Yonatan Lipsitzand 3 more
May 24, 2020
Scalable Purification of Viral Vectors for Gene Therapy: An Appraisal of Downstream Processing Approaches
Separation/Purification
Scalable Purification of Viral Vectors for Gene Therapy: An Appraisal of Downstream Processing ApproachesScalable Purification of Viral Vectors for Gene Therapy: An Appraisal of Downstream Processing Approaches
byMaya Fuerstenau-Sharp, David Pettittand 4 more
Feb 13, 2017

All from Kim Bure

Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Emerging Therapeutics
Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies
Apr 18, 2016
+8
byDavid A. Brindley, Maya Fuerstenau-Sharpand 8 more
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Personalized Medicine
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Automation of CAR-T Cell Adoptive Immunotherapy Bioprocessing: Technology Opportunities to Debottleneck Manufacturing
Apr 18, 2016
+11
byDavid A. Brindley, James A. Smithand 11 more
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Personalized Medicine
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Therapeutic Gene Editing: Tools to Facilitate Basic Science or Stimuli for a Paradigm Shift in Biomanufacturing?
Apr 18, 2016
+3
byEric Roos, James A. Smithand 3 more
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
MAb
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
Decision-Support Tools for Monoclonal Antibody and Cell Therapy Bioprocessing: Current Landscape and Development Opportunities
Dec 16, 2015
+6
byRahul Rekhi, James A. Smithand 6 more
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Cell Therapies
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Quantitative Risk Assessment of Bioaccumulation Attributable to Extractables and Leachables in Cellular Immunotherapy Biomanufacturing
Nov 16, 2015
+2
byKevin Lannon, James A. Smithand 2 more
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Cell Therapies
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use
Apr 15, 2015
+9
byJames A. Smith, Kelvin S. Ngand 9 more
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies logo in a gray background | The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
Cell Therapies
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
The Potential Application of Real‑Time Release Testing for the Biomanufacture of Autologous Cell‑Based Immunotherapies
Apr 15, 2015
+7
byDavid A. Brindley, Rahul Rekhiand 7 more
Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence" logo in a gray background | Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence"
Business
Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence"
Tabular Data for "Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence"
Mar 1, 2014
+5
byDavid A. Brindley, Anna L. Frenchand 5 more
Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence logo in a gray background | Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence
Cell Culture Media
Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence
Cell Therapy Bioprocessing Technologies and Indicators of Technological Convergence
Mar 1, 2014
+5
byDavid A. Brindley, Anna L. Frenchand 5 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024